Download PDF
Thromb Haemost 1964; 12(02): 391-395
DOI: 10.1055/s-0038-1655553
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

On the Combined Administration of Streptokinase and Pancreatic Trypsin Inhibitor

M Verstraete
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
J Vermylen
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
C Vermylen
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
,
R. A De Vreker
1   Laboratory of Coagulation and Proteolysis Department of Medicine, University of Louvain, Belgium
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Preliminary results on the modification of blood fibrinogen level and plasma plasminogen value and fibrinolytic activity during combined administration of streptokinase and pancreatic trypsin inhibitor are presented. Not only fibrinogen fall but also plasminogen depletion is inhibited.

 

  • References

  • 1 Amery A, Maes H, Vermylen J, Verstraete M. The streptokinase reactivity test. I. Standardisation. Thrombos. Diathes. haemorrh. (Stuttg.) 9: 174 1963;
    PubMedGoogle Scholar
  • 2 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch. Biochem. Biophys. 40: 346 1952;
    CrossrefPubMedGoogle Scholar
  • 3 Beck E, Schmutzler B, Duchert F. Inhibition of fibrinolysis and fibrinogenolysis in man: comparison of epsilon-aminocaproic acid and kallikrein inhibitor. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 106 1963;
    PubMedGoogle Scholar
  • 4 Christensen B. B. Methods for measuring the activity of components of the streptococcal fibrinolytic system and streptococcal desoxyribonuclease. J. clin. Invest. 28: 163 1949;
    CrossrefPubMedGoogle Scholar
  • 5 DeV reker B. A. A technique for routine evaluation of plasminogen in humans during streptokinase therapy. (to be published)
    PubMedGoogle Scholar
  • 6 Johnson A. J, McCarty W. B. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase. J. clin. Invest. 38: 1627 1959;
    CrossrefPubMedGoogle Scholar
  • 7 Kline D. B, Fishman J. B. Proactivator function of human plasmin as shown by lysine esterase assay. J. biol. Chem. 236: 2807 1961;
    PubMedGoogle Scholar
  • 8 Bassen M. Heat denaturation of plasminogen in the fibrin plate method. Acta physiol. scand. 27: 371 1952;
    PubMedGoogle Scholar
  • 9 Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol. Rev. 39: 343 1959;
    CrossrefPubMedGoogle Scholar
  • 10 Vermylen C, De Vreker B. A, Verstraete M. A rapid enzymatic method for assay of fibrinogen: Fibrin Polymerisation Time (FPT) test. Clin. chim. Acta 8: 418 1963;
    CrossrefPubMedGoogle Scholar
  • 11 Verstraete M, Amery A, Vermylen J, Vermylen C, De Vreker B. A. Practical method for thrombolytic treatment with streptokinase. Brit. med. J. 675 (1964)
    PubMedGoogle Scholar
  • 12 Verstraete M, Vermylen J, Amery A. The feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. Brit. med. J. I: 1499 1963;
    PubMedGoogle Scholar
  • 13 Verstraete M, Vermylen J, De Vreker B. A, Amery A, Vermylen C. Efficacy of thrombolytic therapy with streptokinase using a new administration scheme. Scand. J. clin. Lab. Invest. Vol. 16 (Suppl. 78) 15-22 1964;
    PubMedGoogle Scholar
  • 14 Zylber J, Blatt W. F, Jensen H. Mechanism of bovine plasminogen activation by human plasmin and streptokinase. Proc. Soc. exp. Biol. 102: 755 1959;
    CrossrefPubMedGoogle Scholar